Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individually adapted immunosuppression in de novo renal transplantation based on immune function monitoring
2009-011623-31Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Apr 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tacrolimus, everolimus, mycophenolate mofetil and methylprednisolone in Kidney allograft status (RTx) (2 arms), sponsored by Ghent University Hospital. Primary endpoints: Difference in measured glomerular filtration rate between study groups and Difference in estimated glomerular filtration rate between study groups. Started Apr 2009; status: completed.
02
Drugs
tacrolimuseverolimusmycophenolate mofetilmethylprednisolone
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2009-011623-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011623-31.